ASHI Meeting Highlights Breakthroughs in Histocompatibility and Immunogenetics Research
ASHI wrapped up its 34th Annual Meeting last month in Toronto. Unprecedented attendance and a superior program made this international conference a definite success. The ASHI Annual Meeting is the world’s leading event for immunologists, geneticists, molecular biologists, transplant physicians and surgeons, pathologists, and technologists looking for the latest cutting-edge findings in laboratory, translational, and clinical histocompatibility and immunology.
The ASHI Annual Meeting, held October 27-31, 2008, at the Sheraton Centre in Toronto, drew a crowd of nearly 1,000 attendees. Those attending gained valuable knowledge through the numerous poster presentations, exhibits, and symposia that highlighted the latest science, technology, and products used to conduct research.
More than 265 abstracts were presented at the meeting, complementing an outstanding program of scientific and educational events. Highlights of the meeting included:
• Transfusion Related Acute Lung Injury (TRALI) update
• Interactive workshops
• Immunoregulatory genes and function
• Genome-wide arrays and gene discovery
• Guiding immunotherapy in autoimmunity
• Case studies on solid organ and bone marrow transplantation
As a professional society involved in histocompatibility, immunogenetics, and transplantation, ASHI is dedicated to advancing the science and application of histocompatibility and immunogenetics; providing a forum for the exchange of information; and advocating the highest standards of laboratory testing in the interest of optimal patient care.
The outstanding lineup of speakers and the opportunity for networking has made this the must-go-to event for professionals in the field. “This meeting provides an unmatched opportunity to exchange information on current and emerging discoveries, forge new collaborations and identify future opportunities in the field,” said Deborah Crowe, Ph.D., D(ABHI), president of ASHI. “The ASHI Annual Meeting provides the most comprehensive source of information in the world on immunogenetic research and its application to human care.”
If you have newsworthy information to add to the ASHI Web site, please contact kmiranda@ahint.com for consideration.